Immunogenicity Summit

Keynote & Featured Speakers

Steve J. Swanson, Ph.D.

Steve SwansonDirector, Medical Sciences, Clinical Immunology, Amgen

Amy Rosenberg, M.D.

Amy RosenbergDirector, Therapeutic Proteins, CDER/FDA

Susan Kirshner, Ph.D.

Susan KirshnerAssociate Chief, Laboratory of Immunology, Therapeutic Proteins, Biotechnology, CDER/FDA

Daniela Verthelyi, M.D., Ph.D.

Daniela VerthelyiChief, Immunology, Therapeutics Proteins, CDER/FDA

Jack Ragheb, M.D., Ph.D.

Jack RaghebPrincipal Investigator, Immunology, Therapeutic Proteins, CDER/FDA

Paul Chamberlain

Paul ChamberlainNDA Advisory Board

Roy Jefferis, Ph.D.,

Roy JefferisC.Chem, FRSC, MRCP, FRCPath, D.S., Professor Emeritus, School of Immunity & Infection, University of Birmingham UK

Valerie Quarmby, Ph.D.

Director and Principal Scientist, BioAnalytical Sciences, Genentech, Inc.

2012 Distinguished Faculty

  • Sathy Balu-Iyer, Ph.D., Associate Professor, Pharmaceutical Sciences, SUNY-University at Buffalo 
  • Paul Chamberlain, NDA Advisory Board 
  • Murty Chengalvala, Ph.D., Program Director, Senior Scientist, Immunology Services, Covance 
  • Jörgen Dahlström, Ph.D., MBA, Scientific Director, ImmunoDiagnostics, Thermo Fisher Scientific 
  • Maureen Deehan, Ph.D., Head, Pharmacology, Experimental Science & Translational Medicine, NovImmune SA 
  • Deborah Finco, Ph.D., Immunotoxicology COE, Pfizer, Inc. 
  • Michele Fiscella, Ph.D., Director, Clinical Immunoassays, Human Genome Sciences 
  • Annie de Groot, Ph.D., Director, Institute for Immunology & Informatics, University of Rhode Island 
  • Timothy Hickling, Ph.D., Associate Research Fellow, PDM Immunogenicity Sciences, Pfizer, Inc. 
  • Josi Holz, M.D., CMO, Ablynx NV 
  • Vibha Jawa, Ph.D., Principal Scientist, Clinical Immunology, Amgen, Inc. 
  • Roy Jefferis, Ph.D., C.Chem., FRSC, MRCP, FRCPath, D.Sc., Professor Emeritus, School of Immunity & Infection, University of Birmingham UK 
  • Wim Jiskoot, Ph.D., Professor, Division of Drug Delivery Technology, Leiden University 
  • Susan Kirshner, Ph.D., Associate Chief, Laboratory of Immunology, Therapeutic Proteins, Biotechnology, CDER/FDA 
  • Stephen Keller, Ph.D., Associate Director II, Pre-Clinical & Clinical Development Sciences, GPRD Abbott iotherapeutics Corp. 
  • Patrick Liu, M.D., Ph.D., Global Head, Bioanalytical Sciences and Technologies, Teva Pharmaceutical Industries, Ltd. 
  • Jim McNally, Ph.D., Senior Principal Scientist, Pfizer, Inc.   
  • Valerie Quarmby, Ph.D., Director and Principal Scientist, BioAnalytical Sciences, Genentech, Inc. 
  • Jack Ragheb, M.D., Ph.D., Principal Investigator, Immunology, Therapeutic Proteins, CDER/FDA 
  • Manoj Rajadhyaksha, Ph.D., Director, Bioanalytical Sciences, Regeneron, Inc.   
  • Theodore W. Randolph, Ph.D., Gillespie Professor of Bioengineering, Chemical and Biological Engineering, University of Colorado 
  • Mazor Ronit, M.Sc., Laboratory of Ira Pastan, Molecular Biology, NIH 
  • Amy Rosenberg, M.D., Director, Therapeutic Proteins, CDER/FDA 
  • Afshin Safavi, Ph.D., Founder and Senior Vice President of Bioanalytical Operations, BioAgilytix Labs 
  • Priya Sriraman, Ph.D., Principal Scientist, DMPK, F. Hoffmann-La Roche 
  • Steve J. Swanson, Ph.D., Executive Director, Medical Sciences, Clinical Immunology, Amgen, Inc. 
  • Daniela Verthelyi, M.D., Ph.D., Chief, Immunology, Therapeutic Proteins, CDER/FDA 
  • Frank F. Weichold, M.D., Ph.D., Director, Clinical Pharmacology and DMPK, Translational Science, MedImmune, LLC 


2013 Brochure Cover

Download Brochure 


Podcast 

IMN Podcast iconReducing and Monitoring Bioassay Variability 

2013 Speaker: Janet L. Lathey, Ph.D., Director, Immunology and Assay Development, BioDefenseDivision, Emergent BioSolutions